| 1 |
APOE genetic variability in an Egyptian cohort of PD |
2025 |
| 2 |
Biallelic variation in the choline and ethanolamine transporter FLVCR1 underlies a severe developmental disorder spectrum |
2025 |
| 3 |
Frequency and risk factors of sleep problems in Egyptian patients with multiple sclerosis |
2025 |
| 4 |
Frequency, Risk Factors, Sex Differences, and Predictors of Post-Stroke Depression: A Multicenter Upper Egypt Study |
2025 |
| 5 |
Mutations in the key autophagy tethering factor EPG5 link neurodevelopmental and neurodegenerative disorders including early‐onset parkinsonism |
2025 |
| 6 |
Nerve ultrasound as an adjunct to nerve conduction studies in Guillain–Barré syndrome diagnosis: a prospective Egyptian case–control study |
2025 |
| 7 |
Outcomes and safety of mechanical thrombectomy, alteplase, and conventional medical care in the treatment of acute M2 segment middle cerebral artery occlusion: a comparative study |
2025 |
| 8 |
Platinum and Taxane-Induced Neuropathy and Its Impact on Quality of Life: A Single Institution Study. |
2025 |
| 9 |
Sleep disorders in a sample of Egyptian patients with Parkinson's disease: a case–control polysomnography study |
2025 |
| 10 |
90. The Clinical and Neurochemical Effect of Transcranial Magnetic Stimulation on the Unusual Symptoms of Multiple Sclerosis |
2024 |
هل لديك سؤال ؟
